Published in Am J Med on February 15, 2003
Correlation between ammonia levels and the severity of hepatic encephalopathy. Am J Med (2003) 1.60
Pharmacological manipulation of cyclic GMP levels in brain restores learning ability in animal models of hepatic encephalopathy: therapeutic implications. Neuropsychiatr Dis Treat (2006) 0.81
Polyethylene Glycol and Lactulose versus Lactulose Alone in the Treatment of Hepatic Encephalopathy in Patients with Cirrhosis: A Non-Inferiority Randomized Controlled Trial. Middle East J Dig Dis (2017) 0.75
Hepatic encephalopathy: what the multidisciplinary team can do. J Multidiscip Healthc (2017) 0.75
Hepatitis C virus infection in USA: an estimate of true prevalence. Liver Int (2011) 3.36
Donor and recipient outcomes in right lobe adult living donor liver transplantation. Liver Transpl (2002) 2.98
Atorvastatin and antioxidants for the treatment of nonalcoholic fatty liver disease: the St Francis Heart Study randomized clinical trial. Am J Gastroenterol (2010) 2.63
Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology (2006) 2.62
Outcomes of living donor liver transplantation for acute liver failure: the adult-to-adult living donor liver transplantation cohort study. Liver Transpl (2008) 2.30
Evaluation of the cost-effectiveness of entecavir versus lamivudine in hepatitis BeAg-positive chronic hepatitis B patients. J Manag Care Pharm (2008) 2.16
Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings. Radiology (2004) 1.80
Analysis of long-term outcomes of 3200 liver transplantations over two decades: a single-center experience. Ann Surg (2005) 1.73
Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation. Hepatology (2005) 1.66
Endoscopic treatment of postorthotopic liver transplantation anastomotic biliary strictures with maximal stent therapy (with video). Gastrointest Endosc (2010) 1.65
Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation. Liver Transpl (2007) 1.58
Serum ferritin concentration predicts mortality in patients awaiting liver transplantation. Hepatology (2010) 1.56
Treating hepatitis C in the prison population is cost-saving. Hepatology (2008) 1.50
Testing for celiac sprue in irritable bowel syndrome with predominant diarrhea: a cost-effectiveness analysis. Gastroenterology (2004) 1.49
MELD score predicts 1-year patient survival post-orthotopic liver transplantation. Liver Transpl (2003) 1.49
Health-related quality of life predicts mortality in patients with advanced chronic liver disease. Clin Gastroenterol Hepatol (2009) 1.42
Structure and Stress: Trajectories of Depressive Symptoms across Adolescence and Young Adulthood. Soc Forces (2009) 1.42
Severe hepatotoxicity due to Hydroxycut: a case report. Dig Dis Sci (2008) 1.38
Kidney transplantation threshold in patients with hepatitis C: a decision analysis model. Transplantation (2015) 1.38
Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma. J Gastroenterol Hepatol (2008) 1.37
Treatment of hepatitis C. Am J Med (2005) 1.35
Optimal resolution in Fresnel incoherent correlation holographic fluorescence microscopy. Opt Express (2011) 1.35
Outcomes of donor evaluation in adult-to-adult living donor liver transplantation. Hepatology (2007) 1.31
Long-term patient outcome and quality of life after liver transplantation: analysis of 20-year survivors. Ann Surg (2010) 1.28
Severe psychiatric problems in right hepatic lobe donors for living donor liver transplantation. Transplantation (2007) 1.26
Pretransplant model to predict posttransplant survival in liver transplant patients. Ann Surg (2002) 1.22
A randomized controlled trial of pretransplant antiviral therapy to prevent recurrence of hepatitis C after liver transplantation. Hepatology (2013) 1.21
Postresection hepatic failure: successful treatment with liver transplantation. Liver Transpl (2007) 1.20
Viral hepatitis in incarcerated adults: a medical and public health concern. Am J Gastroenterol (2009) 1.17
Liver transplantation for fulminant hepatic failure: experience with more than 200 patients over a 17-year period. Ann Surg (2003) 1.15
Risk factors and incidence of de novo malignancy in liver transplant recipients: a systematic review. Liver Int (2010) 1.14
Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C. Liver Transpl (2004) 1.12
Effects of a nurse-managed program on hepatitis A and B vaccine completion among homeless adults. Nurs Res (2008) 1.11
The evolution of liver transplantation during 3 decades: analysis of 5347 consecutive liver transplants at a single center. Ann Surg (2013) 1.08
Immunization needs of chronic liver disease patients seen in primary care versus specialist settings. Dig Dis Sci (2005) 1.03
Pregnancy and cirrhosis. Liver Transpl (2008) 1.01
Pregnancy and liver transplantation. Liver Int (2008) 1.00
A model to predict the development of mental status changes of unclear cause after liver transplantation. Liver Transpl (2003) 1.00
Cardiovascular risk factors following orthotopic liver transplantation: predisposing factors, incidence and management. Liver Int (2010) 1.00
Lamivudine prophylaxis is effective in reducing hepatitis B reactivation and reactivation-related mortality in chemotherapy patients: a meta-analysis. Liver Int (2007) 0.98
Effects of a sustained virologic response on outcomes of patients with chronic hepatitis C. Clin Gastroenterol Hepatol (2011) 0.98
Prediction of survival after liver retransplantation for late graft failure based on preoperative prognostic scores. Hepatology (2004) 0.96
Health-related quality of life after liver transplantation for adult recipients. Liver Transpl (2009) 0.96
Economic burden associated with patients diagnosed with hepatitis C. Clin Ther (2011) 0.95
Comparative analysis of resection and liver transplantation for intrahepatic and hilar cholangiocarcinoma: a 24-year experience in a single center. Arch Surg (2011) 0.95
Hepatitis B surface antigenemia in chronic hemodialysis patients: effect of hepatitis B immunization. Am J Gastroenterol (2002) 0.93
The effects of hepatitis C recurrence on health-related quality of life in liver transplant recipients. Liver Int (2009) 0.93
Factors associated with progression to hepatocellular carcinoma and to death from liver complications in patients with HBsAg-positive cirrhosis. Dig Dis Sci (2009) 0.93
Management of Hepatitis C Antiviral Therapy Adverse Effects. Curr Hepat Rep (2010) 0.92
New era of liver transplantation for hepatitis B: a 17-year single-center experience. Ann Surg (2002) 0.91
Endoscopic treatment with multiple stents for post-liver-transplantation nonanastomotic biliary strictures. Gastrointest Endosc (2009) 0.91
Fulminant liver failure due to usnic acid for weight loss. Am J Gastroenterol (2004) 0.91
The maltose ABC transporter: action of membrane lipids on the transporter stability, coupling and ATPase activity. Biochim Biophys Acta (2013) 0.90
Regional variation in the cost effectiveness of childhood hepatitis A immunization. Pediatr Infect Dis J (2003) 0.89
Balloon-Occluded Retrograde Transvenous Obliteration (BRTO) for Treatment of Gastric Varices: Review and Meta-Analysis. Dig Dis Sci (2014) 0.89
Predictive index for tumor recurrence after liver transplantation for locally advanced intrahepatic and hilar cholangiocarcinoma. J Am Coll Surg (2011) 0.89
Presence and predictors of hepatitis C virus RNA in the semen of homeless men. Biol Res Nurs (2002) 0.87
Complications of cirrhosis. Dis Mon (2008) 0.85
Liver transplantation in the era of model for end-stage liver disease. Liver Int (2004) 0.85
Cirrhosis regression in hepatitis C patients with sustained virological response after antiviral therapy: a meta-analysis. Liver Int (2014) 0.85
Recurrent hepatitis C following liver transplant: diagnosis, natural history, and therapeutic options. J Clin Gastroenterol (2003) 0.84
Primary prevention of cirrhosis. Public health strategies that can make a difference. Postgrad Med (2004) 0.83
The cost effectiveness of hepatitis immunization for US college students. J Am Coll Health (2003) 0.83
Management of recurrent hepatocellular carcinoma in liver transplant recipients: a systematic review. Exp Clin Transplant (2012) 0.82
Hepatitis C and lymphoproliferative disorders: from mixed cryoglobulinemia to non-Hodgkin's lymphoma. Clin Gastroenterol Hepatol (2009) 0.82
Hyponatremia: clinical associations, prognosis, and treatment in cirrhosis. Exp Clin Transplant (2013) 0.82
Patients with nodular regenerative hyperplasia should be considered for hepatocellular carcinoma screening. Hepatol Res (2013) 0.81
A comparison of hepatitis B viral markers of patients in different clinical stages of chronic infection. Hepatol Int (2010) 0.81
Liver transplantation for hepatitis B liver disease and concomitant hepatocellular carcinoma in the United States With hepatitis B immunoglobulin and nucleoside/nucleotide analogues. Liver Transpl (2013) 0.81
Deciding liver transplant candidacy: tools of the trade. Liver Int (2008) 0.80
Capsule endoscopy is not as accurate as esophagogastroduodenoscopy in screening cirrhotic patients for varices. Clin Gastroenterol Hepatol (2011) 0.80
Effect of nonviral factors on hepatitis C recurrence after liver transplantation. Ann Surg (2006) 0.80
Timing of Hepatitis C Antiviral Therapy in Liver Transplant Recipients With Direct-acting Agents. Exp Clin Transplant (2016) 0.80
Recurrence of non-viral liver disease after orthotopic liver transplantation. Liver Int (2011) 0.80
An economic assessment of pre-vaccination screening for hepatitis A and B. Public Health Rep (2003) 0.80
Acute Epidural Hematoma Formation in Cervical Spine After Interlaminar Epidural Steroid Injection Despite Discontinuation of Clopidogrel. Reg Anesth Pain Med (2016) 0.78
Hepatitis C disease severity in living versus deceased donor liver transplant recipients: an extended observation study. Hepatology (2014) 0.78
Pegylated Interferon and Ribavirin Dosing Strategies to Enhance Sustained Virologic Response. Curr Hepat Rep (2010) 0.78
The role of mammalian target of rapamycin inhibitors in the management of post-transplant malignancy. Clin Transplant (2014) 0.78
Cirrhosis regression in patients with viral hepatitis B and C: a systematic review. J Clin Gastroenterol (2014) 0.77
Hepatitis C and work impairment: a review of current literature. J Clin Gastroenterol (2014) 0.77
Impact of nutrition and obesity on chronic liver disease. Clin Liver Dis (2013) 0.77
A proposed, evidence-based approach to the treatment of chronic Hepatitis B. J Clin Gastroenterol (2011) 0.77
Assessment of cost of innovation versus the value of health gains associated with treatment of chronic hepatitis C in the United States: The quality-adjusted cost of care. Medicine (Baltimore) (2016) 0.77
Recurrent non-alcoholic steatohepatitis in a living related liver transplant recipient. J Hepatol (2005) 0.77
Inpatient economic and mortality assessment for liver transplantation: a nationwide study of the United States data from 2005 to 2009. Transplantation (2014) 0.77
Timing of Hepatitis C Antiviral Therapy in Liver Transplant Recipients With Direct-acting Agents. Exp Clin Transplant (2016) 0.76
Correction: Transcriptional profiling at whole population and single cell levels reveals somatosensory neuron molecular diversity. Elife (2015) 0.76
Cirrhosis with refractory ascites: serial large volume paracentesis, TIPS, or transplantation? Clin Gastroenterol Hepatol (2011) 0.76
Can daily coffee consumption reduce liver disease-related mortality? Clin Gastroenterol Hepatol (2013) 0.75
Multicenter review of liver transplant for hepatitis B-related liver disease: disparities in gender and ethnicity. Clin Transplant (2013) 0.75
A parathyroid hormone-related protein-secreting metastatic epithelioid leiomyosarcoma. A case report and review of the literature. Arch Pathol Lab Med (2003) 0.75
Efficacy of CT angiography for preoperative vascular mapping in adult to adult living related liver transplant donors. J Med Assoc Thai (2011) 0.75
Serving God and Country? Religious Involvement and Military Service among Young Adult Men. J Sci Study Relig (2009) 0.75
Liver transplant: a primer. Exp Clin Transplant (2010) 0.75
Treatment of Patients With Hepatitis C Virus infection (Genotype 4) With Ledipasvir-Sofosbuvir in the Liver Transplant Setting. Transplantation (2017) 0.75
Age-related Morbidity and Mortality After Transjugular Intrahepatic Portosystemic Shunts. J Clin Gastroenterol (2017) 0.75
Viral breakthrough is associated with resistance using direct acting agents in patients treated for chronic hepatitis C infection. J Clin Gastroenterol (2014) 0.75